[Edaily Reporter KIM HYUNSIK ] The “global idol” group BTS is set to kick off the Asian and Australian leg of their “ARIRANG” world tour. (Photo courtesy of Big Hit Music)According to their agency, Big Hit Music, on the 19th, BTS will hold an “ARIRANG” concert at the Kaohsiung National Stadium in Taiwan. BTS will also meet fans at the same venue on the 21st and 22nd. To commemorate the concert, Kaohsiung City illuminated major landmarks—including the 85 Building, the Aihe River, the Dajian Bridge, and the Kaohsiung Music Center—in purple, the symbolic color of BTS and their fanbase, “ARMY.” A lighting show projecting welcome messages such as “THE CITY IS YOURS ARMY” was displayed on the exterior of the 85 Sky Tower. A BTS-themed photo zone has been set up at Kaohsiung International Airport, and messages welcoming the group have appeared on subway turnstile screens, drawing attention. Kaohsiung City has also organized various tourism programs, including discounts at night markets and shops, to attract concertgoers to local commercial districts and tourist attractions. BTS will hold a total of 21 concerts in seven Asian cities, including Kaohsiung, Bangkok, Kuala Lumpur, Singapore, Jakarta, Hong Kong, and Bulacan. Their Australian tour will consist of five concerts in Melbourne and Sydney next February. In December, when the Singapore concerts begin, the group will launch “BTS THE CITY ARIRANG – SINGAPORE,” an urban project featuring a variety of promotional programs such as drone shows and light shows. Meanwhile, BTS was named the winner in the “Best International Artist” category at the “2026 ARIA Awards,” a pop music awards ceremony held in Sydney, Australia, on the 18th.
Digital asset venture capital (VC) firm Hashed has begun promoting collaboration between companies and developers through artificial intelligence (AI). Hashed announced on the 19th that it had hosted …
NamyangDairyProducts(003920)’s protein brand “TakeFit” saw its cumulative sales for the third quarter of this year increase by 48.3% compared to the same period last year. Analysts attribute this grow…
“Through a study on patient-derived tissue recently presented at the Society for Immunotherapy of Cancer (SITC) in the U.S., we have confirmed the potential for our next-generation immuno-oncology dru…